Categories
Resources
Your Recalls
Loading...
Get email alerts when new recalls match your interests.
Due to an issue with the internal clock of the analyzers with an e3800 PC unit installed.
The firm has received reports of stent migration after implantation
Failed Impurities/degradation specifications: Repackager recall due to Out of Specification detected by manufacturer for Individual Unidentified Impurity found during related substance test analysis of Cephalexin
Due to distributing test kits to customers who were not part of a clinical investigation.
Failed Impurities/Degradation Specifications:
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/ or tadalafil
Recall reason is possible sporadic false negative conventional troponin results. Roche has confirmed an issue with running Elecsys Troponin I/Troponin I STAT and Elecsys proBNP II/proBNP II STAT on the cobas e 601 and 602 modules. When the proBNP II analyte is measured immediately before the Troponin I analyte on the same module, a decreased recovery on Troponin I was observed.
A longevity estimation error may occur in the early years of device life when a unipolar pacing vector is programmed in the right atrial (RA) lead and/or the right ventricular (RV) lead. No other device features or therapies are impacted.
There is a SmartSync software issue that results in an overestimation in the displayed longevity of these devices during an approximate 6-month window of time before the device triggers its Recommended Replacement Time (RRT).
Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.